Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis

NCT05005910 is registered in ClinicalTrials.gov with Uayporn Kaosombatwattana as lead sponsor.

NCT NCT05005910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
Lead sponsor
Uayporn Kaosombatwattana
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2021
Completion date
December 1, 2022
Enrollment
194 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peptic ulcer with haemorrhage